Table II.
The individual sub-item self-report adherence score and the 3-item adherence scale mean score overall by timepoint and viral load suppression status (n=431)
| Overall | Detectable viral load | Undetectable viral load | |||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Mean (SD) | Median | Mean (SD) | Median | Mean (SD) | Median | ||
|
|
|||||||
| Baseline (n= 48, 11%) | Days taken | 72.0 (41.0) | 96.7 | 50.9 (48.6) | 70.0 | 89.9 (22.9) | 100.0 |
| Frequency | 69.4 (30.3) | 60.0 | 55.4 (31.1) | 25.0 | 81.1 (24.5) | 80.0 | |
| Rating | 56.9 (36.3) | 80.0 | 40.4 (33.7) | 30.0 | 70.8 (32.8) | 100.0 | |
| 3-item scale | 66.1 (33.5) | 74.5 | 48.9 (35.3) | 55.0 | 80.6 (24.1) | 88.9 | |
|
| |||||||
| 6-months (n= 160, 37%) | Days taken | 88.3 (23.9) | 100.0 | 75.0 (33.3) | 93.3 | 91.9 (19.2) | 100.0 |
| Frequency | 81.0 (23.8) | 80.0 | 69.7 (28.3) | 60.0 | 84.0 (21.5) | 80.0 | |
| Rating | 71.8 (29.3) | 80.0 | 55.0 (33.8) | 80.0 | 76.3 (26.3) | 100.0 | |
| 3-item scale | 80.4 (23.1) | 86.7 | 66.6 (28.6) | 72.2 | 84.1 (19.9) | 86.7 | |
|
| |||||||
| 12-months (n= 142, 33%) | Days taken | 88.3 (24.5) | 98.4 | 69.6 (39.1) | 90.0 | 94.6 (11.7) | 100.0 |
| Frequency | 82.7 (23.1) | 80.0 | 62.8 (26.9) | 60.0 | 89.4 (17.2) | 100.0 | |
| Rating | 74.4 (28.7) | 100.0 | 54.4 (31.6) | 60.0 | 81.2 (24.3) | 100.0 | |
| 3-item scale | 81.8 (23.0) | 86.7 | 62.3 (29.5) | 71.7 | 88.4 (15.8) | 93.3 | |
|
| |||||||
| 18-months (n= 81, 19%) | Days taken | 92.9 (17.6) | 100.0 | 74.7 (34.3) | 86.7 | 97.0 (5.8) | 100.0 |
| Frequency | 87.3 (22.7) | 100.0 | 71.3 (31.4) | 80.0 | 90.9 (18.8) | 100.0 | |
| Rating | 79.4 (26.8) | 100.0 | 60.0 (35.0) | 80.0 | 83.8 (22.7) | 100.0 | |
| 3-item scale | 86.5 (19.7) | 97.8 | 68.7 (29.1) | 81.1 | 90.6 (14.3) | 98.9 | |
Abbreviations: SD, standard deviation
Since adherence and outcomes were assessed at multiple time points, we have 431 separate observations for the 336 participants included in this analysis